NotizieBenzingaNovo Nordisk Announces New Retrospective Real-world Evidence For Type 2 Diabetes Showing Semaglutide Injection 2 Mg Was Associated With A Statistically Significant 6% Lower Risk Of Major Adverse Cardiovascular Events, Than Those Who Switched To... Novo Nordisk Announces New Retrospective Real-world Evidence For Type 2 Diabetes Showing Semaglutide Injection 2 Mg Was Associated With A Statistically Significant 6% Lower Risk Of Major Adverse Cardiovascular Events, Than Those Who Switched To... Benzinga 2026.09.29 10:35 (GMT+0) Apri Benzinga Altre notizie Il chief development officer di Mid Penn Bancorp vende azioni per $40 Il presidente di Oxford Square Capital Corp acquista azioni per $24.597 Il CEO di Oxford Square Capital acquista azioni per $24.598 Titolo del giorno: Quanto in basso scenderà Micron? Il direttore di Comstock Inc Leo Drozdoff acquista azioni per $19.950 Il CEO di Comstock Inc. Corrado De Gasperis acquista azioni per $14.962